[TEVA] YoY Annual Result on 31-Dec-2020 [#FY]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
10-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#FY]
Profit Trend
YoY- -299.40%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 15,845,000 14,925,000 15,878,000 16,658,000 16,887,000 18,854,000 22,385,000 -5.59%
PBT -624,000 -3,065,000 658,000 -4,406,000 -1,265,000 -2,596,000 -18,379,000 -43.08%
Tax -7,000 -638,000 211,000 -168,000 -278,000 -195,000 -1,933,000 -60.79%
NP -559,000 -2,353,000 417,000 -3,990,000 -999,000 -2,150,000 -16,265,000 -42.96%
Tax Rate - - -32.07% - - - - -
Total Cost 16,404,000 17,278,000 15,461,000 20,648,000 17,886,000 21,004,000 38,650,000 -13.30%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -3.53 -15.77 2.63 -23.95 -5.92 -11.40 -72.66 -39.58%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.50 -2.12 0.38 -3.64 -0.92 -2.11 -16.01 -43.86%
EPS Diluted -0.50 -2.12 0.38 -3.64 -0.92 -2.11 -16.01 -43.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.